Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

Portfolio

Loading...
Select Portfolio and Asset Combination for Display on Market Band
Select Portfolio
Select Asset Class
Show More
Download ET MARKETS APP

Get ET Markets in your own language

DOWNLOAD THE APP NOW

+91

CHOOSE LANGUAGE

ENG

  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা
  • KAN - ಕನ್ನಡ
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
Drag according to your convenience
ET NOW RADIO
ET NOW
TIMES NOW

Godrej Agrovet IPO off to a good start; gets subscribed over 16% on Day 1

ETMarkets.com|
Updated: Oct 04, 2017, 01.29 PM IST
0Comments
Godrej Industries owns 60.81 per cent stake in Godrej Agrovet.
Godrej Industries owns 60.81 per cent stake in Godrej Agrovet.
NEW DELHI: The Rs 1,157 crore initial public offer (IPO) of Godrej Agrovet (GAVL) was subscribed 16.43 per cent on the first day of the bidding process on Wednesday. By 1.20 pm, the public offer received bids for 29,63,008 shares against 1,80,27,464 shares on offer.

On Tuesday, the company allotted 74.17 lakh shares to 25 anchor investors including Reliance Capital Trustee Company, SBI Life Insurance Company, Nomura, Goldman Sachs, Government of Singapore, among others, at Rs 460 apiece.

Godrej Industries owns 60.81 per cent stake in Godrej Agrovet and intends to use the IPO proceeds towards loan repayments and other general purposes.

The company is the largest palm oil producer in India. It's joint venture in Bangladesh is the fourth largest feed producer in terms of sales volume.

Analysts have said given the strong fundamentals and market share the company enjoys, the issue is a 'Subscribe'. Buy at cut off price, brokerage advised retail investors.

IIFL Investment Managers, which have a subscribe rating on the issue, said that the company has successfully reaped the rewards of astute business integration. Its synergies across various businesses drive growth, optimise capital efficiency and define its competitive edge, it said.

"GAVL has made strategic acquisitions and joint ventures including Aztec LifeSciences and Creamline Dairy, enabling it to consolidate its market position in existing business verticals through synergy benefits, product portfolio expansion, technological advancement and enhanced sales and distribution network. Thanks to extensive procurement, sales and distribution network and strong brand recall, GAVL has gained enviable market share," it said.

In four years to FY17, the company’s top line and bottom line grew at a compounded annual growth rate of 12.2 per cent and 27.3 per cent respectively.

" At the price band of Rs. 450-460, the issue is priced at 34-34.7 times of its FY17 earnings, whereas it is available at 18-18.4 times FY17 EV/EBITDA. For FY17, the pre-issue return on equity and return on capital employed stood at 28.4 per cent and 28.9 per cent respectively. We recommend investors to subscribe the issue at cut-off price," SBICap Securities said in a note.

ICICIdirect.com says that GAVL is available at market cap to sales ratio of 1.8 times on FY17 basis.

It possess healthy balance sheet with net debt to equity ratio of 0.6, average net working capital days of nearly 30 and robust return on equity at 28 per cent. The brokerage recommended a subscribe rating on the issue.

" At 33.5 times, GAVL does not appear expensive as PE multiple is in the mid of this range and ROE is at the higher end of the range. We assign a subscribe rating to this IPO considering its diversified business profile, decent margins, strong return ratios, healthy balance sheet and strong history of its parent,” Angel Broking said.

Also Read

Godrej Agrovet IPO kicks off; here's what top brokerages say

Godrej Agrovet IPO kicks off; here's what top brokerages say

Godrej Industries to raise Rs 400 crore through Godrej Agrovet IPO

Comments
Add Your Comments

Loading
Please wait...